The effect of COVID-19 on routine diabetes care and mortality in people with diabetes

Hopkins, David; Rubino, Francesco

doi:10.1016/s2213-8587(22)00162-0

The Lancet Diabetes & Endocrinology

2022

DOI: 10.1016/s2213-8587(22)00162-0

|View full text |Cite

The effect of COVID-19 on routine diabetes care and mortality in people with diabetes

David Hopkins

Francesco Rubino

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Disruption to clinical studies and trials as well as routine care may have practical implications [15] as could the impact of disruption on early career researchers [2] . However, it also a possibility that because of Covid-19 there may also be a different focus within diabetes research itself – a move away from funding of ‘traditional’ research areas to other themes.…”

mentioning

confidence: 99%

Diabetes and Covid-19: Diabetes research funding and support during the pandemic

Hills

Meadows

Felton

et al. 2023

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

mentioning

confidence: 99%

Diabetes and Covid-19: Diabetes research funding and support during the pandemic

Hills

Meadows

Felton

et al. 2023

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

A Hybrid Model of In-Person and Telemedicine Diabetes Education and Care for Management of Patients with Uncontrolled Type 2 Diabetes Mellitus: Findings and Implications from a Multicenter Prospective Study

Tourkmani,

Alharbi,

Rsheed

et al. 2024

Telemedicine Reports

View full text Add to dashboard Cite

Background: Patients with uncontrolled type 2 diabetes mellitus (T2DM) require close follow-up, support, and education to achieve glycemic control, especially during the initiation or intensification of insulin therapy and self-care management. This study aimed to describe and evaluate the impact of implementing a hybrid model of in-person and telemedicine care and education on glycemic control for patients with uncontrolled T2DM (hemoglobin A1c [HbA1c] ≥9%) during the coronavirus disease pandemic. Methods: This prospective multicenter-cohort pre-/post-intervention study was conducted on patients with uncontrolled T2DM. This study included three chronic illness centers affiliated with the Family and Community Medicine Department at Prince Sultan Military Medical City in Riyadh, Saudi Arabia. A hybrid model of in-person (onsite) and telemedicine care and education was developed. This involved implementing initial in-person care at the physicians' clinic and initial in-person education at the diabetes education clinic, followed by telemedicine services of tele-follow-ups, support, and education for an average 4-month follow-up period. Results: Of the enrolled 181 patients, more than half of the participants were women ( n = 103, 56.9%). The mean age of participants (standard deviation) was 58.64 ± 11.23 years and the mean duration of diabetes mellitus was 13.80 ± 8.55 years. The majority of the patients ( n = 144; 79.6%) were on insulin therapy. Overall, in all three centers, the hybrid model had significantly reduced HbA1c from 10.47 ± 1.23% to 7.87 ± 1.59% (mean difference of reduction 2.59% [95% confidence interval (CI) = 2.34–2.85%], p < 0.001). At the level of each center, HbA1c was reduced significantly with mean differences of 3.17% (95% CI = 2.81–3.53%), 2.49% (95% CI = 1.92–3.06%), and 2.16% (95% CI = 1.76–2.57%) at centers A, B, and C, respectively (all p < 0.001). Conclusion: The findings showed that the hybrid model of in-person and telemedicine care and education effectively managed uncontrolled T2DM. Consequently, the role of telemedicine in diabetes management could be further expanded as part of routine diabetes care in primary settings to achieve better glycemic control and minimize nonessential in-person visits when appropriate.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The effect of COVID-19 on routine diabetes care and mortality in people with diabetes

Cited by 2 publications

References 8 publications

Diabetes and Covid-19: Diabetes research funding and support during the pandemic

Diabetes and Covid-19: Diabetes research funding and support during the pandemic

A Hybrid Model of In-Person and Telemedicine Diabetes Education and Care for Management of Patients with Uncontrolled Type 2 Diabetes Mellitus: Findings and Implications from a Multicenter Prospective Study

Contact Info

Product

Resources

About